ANDA 72429, held by Strides Pharma Intl. Fenoprofen Calcium.
As of Nov 16, 2026, ANDA 72429 (Fenoprofen Calcium), held by Strides Pharma Intl, was first approved by FDA on Jul 19, 1988, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 19, 1988 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fenoprofen CalciumEQ 600MG BASE · tablet;oral | Fenoprofen Calcium | Discontinued |
| Nov 21, 2024 | Supplement 9Labeling · Standard review | Approved | None posted |
| Apr 28, 2021 | Supplement 8Labeling · Standard review | Approved | None posted |
| Apr 21, 1994 | Supplement 5Manufacturing | Approved | None posted |
| May 31, 1991 | Supplement 7Labeling | Approved | None posted |
| Sep 7, 1989 | Supplement 6Bioequivalence | Approved | None posted |
| May 12, 1989 | Supplement 4Labeling | Approved | None posted |
| Mar 31, 1989 | Supplement 3Labeling | Approved | None posted |
| Jul 19, 1988 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters